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Available onlineAbstract
Clinical and environmental strains of Burkholderia cenocepacia belonging to the recA lineages IIIA and IIIB were examined for
exopolysaccharide (EPS) production. The exopolysaccharides structure was determined using mainly gas chromatography coupled to mass
spectrometry and NMR spectroscopy. All the strains produced Cepacian, a highly branched polysaccharide constituted of a heptasaccharide
repeating unit, composed of one rhamnose, one glucose, one glucuronic acid, one mannose and three galactose residues. This polymer is the
most common exopolysaccharide produced by strains of the Burkholderia cepacia (Bcc) complex. One clinical strain produced also another
polysaccharide constituted of three galactose units and one 3-deoxy-D-manno-2-octulosonic acid residues, a polymer that was previously
isolated from two strains of B. cepacia genomovar I and B. cenocepacia IIIA.
D 2004 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Burkholderia cenocepacia; recA lineages; Exopolysaccharide; Structure1. Introduction
Burkholderia cepacia complex (Bcc) is an important
group of opportunistic human pathogens in patients affected
by cystic fibrosis (CF) or chronic granoulomatous disease.
Among the nine species or genomovars included in the Bcc,
Burkholderia cenocepacia (previously known as B. cepacia
genomovar III) [1] accounts for the majority of isolates from
CF patients, comprising the most virulent and transmissible
strains, often associated with a poor clinical course and high
mortality of CF patients.
Based on the polymorphism of the recA gene, recent
papers showed that B. cenocepacia is genetically highly
heterogeneous being composed of at least four phylogenetic1569-1993/$ - see front matter D 2004 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2004.04.004
* Corresponding author. Tel.: +39-040-5583685; fax: +39-040-5583691.
E-mail address: cescutti@bbcm.units.it (P. Cescutti).lineages (IIIA, IIIB, IIIC, and IIID) [2,3]. However, a
worldwide distribution among CF patients has been estab-
lished so far only for the lineages IIIA and IIIB. They are
responsible for the majority of infection cases [3], with
strains belonging to the lineage IIIA characterised seeming-
ly by a higher transmissibility and mortality rate than the
IIIB strains [4]. Little is known about the pathogenic
determinants of this bacterium but some putative virulence
factors have been listed. These include iron-chelating side-
rophores, pili, outer-membrane proteins, extracellular
enzymes, intracellular survival, lipopolysaccharides, and
exopolysaccharides (EPS).
Bacterial EPSs are established virulence factors that act
favouring evasion of host defence mechanisms, bacterial
adhesion, and resistance to antibacterial agents. Recently,
Chung et al. [5] observed that a virulent variant of a strain of
B. cenocepacia showed an increase in EPS biosynthesis,
suggesting an association between abundant EPS productioned by Elsevier B.V. All rights reserved.
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at the moment, it is still not clear whether EPS produced by
Bcc has a functional role similar to that of the alginate
produced by mucoid isolates of Pseudomonas aeruginosa
[6].
It was demonstrated by different laboratories that B.
cepacia mostly synthesises one type of EPS constituted of
a highly branched heptasaccharide repeating unit (Fig. 1,
Formula 1) [5,7–10]; due to its high recurrence, it was
proposed to name it Cepacian [11]. It was also observed that
Cepacian is often co-produced with other polysaccharidic
species [9]. On the other hand, two clinical strains isolated
from CF patients attending the Cystic Fibrosis Center in
Trieste (Italy) produced a polysaccharide totally different
from Cepacian (Fig. 1, Formula 2) [9,12].
The correlation between Bcc species and type of EPS
produced is not feasible at the moment, since generally the
studies of the chemical structure of EPSs were not supported
by the determination of the microbial species. Only recently,
EPSs produced by a number of clinical strains with known
species status were more systematically investigated [9].
The identification of as much as nine species within the Bcc
raised the question whether all the species produce the same
type of EPS. Furthermore, a comparison between strains of
environmental and clinical origin has never been comprised
in such studies, although it is generally accepted thatFig. 1. Formulas of the four exopolysacchariinfections of CF patients by Bcc may occur by direct
acquisition of Bcc strains from the natural environment.
In an effort to gain a more complete and reliable picture
of the type of EPS synthesised by the two most diffused
recA lineages (IIIA and IIIB) of B. cenocepacia, EPSs
produced by strains isolated from CF patients (IIIA and
IIIB strains) and from the rhizosphere of maize (IIIB strains)
were studied. Their structure was determined using mainly
gas chromatography coupled to mass spectrometry and
NMR spectroscopy.2. Materials and methods
2.1. Bacterial strains, identification, and RAPD
fingerprinting
Six clinical isolates were obtained from the sputum of CF
patients [13] attending the Gaslini Hospital (Genoa, Italy)
and three environmental isolates were recovered from the
rhizosphere of maize [14] in three different sites located in
Northern, Central and Southern Italy (Table 1). Identifica-
tion of isolates was accomplished according to the proce-
dure previously described [2].
Each isolate was genetically typed by random amplified
polymorphic DNA (RAPD) analysis as described bydes produced by B. cepacia complex.
Table 1
Bacterial strains
Strain Origin recA lineage RAPD type
FC30 sputum of CF patient IIIA I
FC42 sputum of CF patient IIIA I
FC52 sputum of CF patient IIIA II
FC24 sputum of CF patient IIIB III
FC75 sputum of CF patient IIIB IV
FC87 sputum of CF patient IIIB V
MDIIP144 rhizosphere of maize IIIB VI
MDIIR129 rhizosphere of maize IIIB VII
MVPC12 rhizosphere of maize IIIB VIII
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compared by eye and computer software (Kodak 1D Image
Analysis Software, NY). Reproducibility was verified by
RAPD fingerprinting each isolate at least four times in
independent experiments. Different isolates exhibiting ge-
netic fingerprints differing by no more than two bands were
considered genetically related and, thus, belonging to the
same RAPD type. Isolates producing genetic fingerprints
that did not match others within the bacterial population
were designated as unique.
2.2. Isolation and purification of the exopolysaccharides
Bacterial cells were grown for 4 or 5 days at 30 jC on a
solid medium containing 2 g of yeast extract, 20 g of
mannitol and 15 g of bacto agar per litre (medium MM).
The bacteria were harvested by scraping the agar plates
using a 0.9% NaCl solution (about 5 ml for each plate). To
the obtained suspension, phenol was added at a final
concentration of 5%. After stirring at 4 jC for 5 h, the cells
were removed by centrifugation. The EPS was precipitated
from the supernatant by addition of 4 volumes of isopropa-
nol and then the precipitated material was dissolved in
water. The procedure was repeated three times. The EPS
was dialysed first against 0.1 M NaCl and then against
water, the pH adjusted to neutrality and the polymer was
recovered by freeze-drying. When nucleic acids and pro-
teins were present, they were removed by treatment with
DNAse, RNAse and proteinase.
2.3. General analytical methods
The colorimetric phenol–sulphuric acid assay [16] was
used to determine the neutral sugars present in the samples,
while the test developed by Blumenkrantz and Asboe-
Hansen [17] was applied to the colorimetric determination
of uronic acids.
Analytical GLC was performed with an AutoSystem XL
(Perkin Elmer) gas chromatograph equipped with a flame
ionisation detector, using He as the carrier gas. GLC-MS
analyses were carried out on a Hewlett-Packard 5890 gas
chromatograph coupled to a Hewlett Packard 5971 mass
selective detector.Hydrolysis of the EPSs was carried out in 2 M CF3CO2H
at 125 jC for 1 h. The O-acetyl groups were removed by
treatment with 0.01 M NaOH at room temperature for 5 h
[18].
2.4. Composition analysis of exopolysaccharides
Alditol acetates were prepared as described previously
[19] using inositol as internal standard. The derivatives
were separated by GLC using a SP2330 capillary col-
umn (Supelco 30 m) and the temperature program: 1
min at 200 jC, 200–245 jC at 4 jC/min, 20 min at
245 jC.
Methanolysis was performed with 1 M HCl in methanol
(Supelco) at 85 jC for 18 h according to Dudman et al. [20].
Trimethylsilyl derivatives were obtained incubating the
mixture of methyl glycosides with Sylon HTP kit
(HMDS+TMCS+ Pyridine, 3:1:9, Supelco) at room tem-
perature for 1 h. The products were dried under a stream of
N2, dissolved in n-hexane, centrifuged to remove insoluble
materials and the supernatant was dried under a stream of
N2. The mixtures of derivatives were separated on a HP1
column (Hewlett-Packard, 50 m) using the following tem-
perature program: 1 min at 150 jC, 150–280 jC at 3 jC/
min, 20 min at 280 jC.
The absolute configuration of the sugar residues was
established via GLC analysis of the trimethylsilylated (+)-2-
butyl glycosides [21,22], which were separated on a HP1
column (Hewlett-Packard, 50 m) using the temperature
program: 1 min at 135 jC, 135–240 jC at 1 jC/min, 20
min at 240 jC.
2.5. Linkage analysis
The samples were sonicated to reduce the molecular
weight and exchanged into the protonated form prior to
chemical reactions. Methylations were performed accord-
ing to Dell [23] but using potassium methylsulfinyl-
methanide [24]. After methylation, the permethylated
samples were purified on Sep-Pak C18 cartridge, [25]
prior to hydrolysis, and derivatisation into alditol ace-
tates. The products were analysed by GLC and GLC-MS
using an SP2330 capillary column (Supelco, 30 m), and
the temperature program: 1 min at 150 jC, 150–250 jC
at 4 jC/min, 20 min at 250 jC. Molar ratio values were
corrected by use of effective carbon-response factors
[26].
2.6. 1H-NMR spectroscopy
NMR spectra were recorded on a VarianUNITY INOVA
NMR spectrometer operating at 500 MHz (1H) at 50 jC.
Samples, previously sonicated to decrease the molecular
weight, were exchanged three times with 99.96% deuterium
oxide by lyophilisation, and finally dissolved in 99.96%
deuterium oxide. Chemical shifts are expressed in ppm
Table 3
Linkage analysis of polysaccharides
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ppm for 13C).
Linked sugara Relative molar ratios
RRTb Cepacian FC24 FC30 FC87 MDIIP144
2-Rha 0.80 1.00 1.00 1.00 1.00 1.00
t-Gal 0.88 2.88 2.62 2.97 2.36 2.90
3-Glc 1.00 1.02 1.08 1.12 1.12 1.06
2-Hexf c 1.02 0.12
4-Glc 1.09 0.43 0.20
6-Gal 1.14 0.27 0.25 0.26
3,6-Man 1.27 0.43 0.54 0.61 0.81 0.67
4,6-Glc 1.28 0.06 0.03
a The numbers indicate the position of the glycosidic linkage, t stands
for non-reducing terminal.
b Retention time relative to 3-linked glucose.
c Unidentified 2-linked hexose in the furanose form.3. Results
3.1. Identification and typing of the isolates
All isolates were classified as B. cenocepacia; six of them
(three clinical and the environmental isolates) were assigned
to recA lineage IIIB, whereas the remaining three isolates of
clinical origin were assigned to recA lineage IIIA (Table 1).
Amplification of genomic DNAs of the B. cenocepacia
isolates gave rise to a total of 45 bands. Each RAPD pattern
was constituted of 8 to 28 bands (mean value, 19 bands). Each
isolate showed the same amplification pattern in four inde-
pendent experiments (data not shown). All environmental
isolates had unique RAPD fingerprints as well as the clinical
isolates belonging to recA lineage IIIB (Table 1). Two of the
clinical isolates (FC30 and FC42) belonging to recA lineage
IIIA turned out to belong to the same RAPD type, whereas the
other one (FC52) had a different RAPD fingerprint (Table 1).
3.2. Exopolysaccharides production
The bacterial strains were grown on solid medium con-
taining excess of mannitol as carbon source (medium MM),
previously reported to increase the production of EPS [27].
Each strain was grown on the same number of Petri dishes,
and remarkably the clinical strains produced on the average
more EPS than the environmental strains (404 and 290 mg,
respectively).
3.3. Composition analysis of exopolysaccharides
The colorimetric tests showed a content of neutral sugars
between 59% and 78% and of uronic acids between 16%
and 23%. The composition of the exopolysaccharides was
obtained after hydrolysis of the polymers and derivatisation
into alditol acetates. All the samples contained rhamnose,
mannose, galactose and glucose in similar amounts. The
results obtained were compared with the composition of
Cepacian (Table 2).
Methanolysis of the exopolysaccharides, followed by
derivatisation of the methyl glycosides into trimethylsilyl
ethers, gave rhamnose, mannose, galactose, glucose and
glucuronic acid, the latter in low amounts, probably due toTable 2
Molar percentages of neutral sugars in the polysaccharides samples compared wi
Sugar Cepacian FC 24 FC30 FC42 FC52
Rha 18 18 22 25 21
Man 12 8 8 8 6
Gal 48 45 49 47 57
Glc 22 29 22 21 16its high resistance to cleavage. The sample FC52 contained
the same sugars mentioned above together with Kdo. The
absolute configuration of the neutral sugars was D. No
information was obtained for the Kdo residue and for the
glucuronic acid, due to its high resistance to methanolysis.
3.4. Linkage analysis
Four samples, FC24, FC30, FC87 and MDIIP144, were
subjected to linkage analysis (Table 3) and the data were
compared with those described for Cepacian [8]. All the
samples contained 2-linked rhamnose, terminal-galactose,
3-linked glucose and 3,6-linked mannose with molar ratios
very similar to those of Cepacian. The sample FC30
contained only the sugar residues attributable to Cepacian,
while the samples FC24, FC87 and MDIIP144 showed
minor extraneous components. Sugar residues present in
less than 10% were not considered.
3.5. 1H-NMR spectroscopy
All samples were analysed by means of NMR spec-
troscopy. As an example, the 1H-NMR spectrum of FC42
is reported in Fig. 2. The relevant signals occur in three
regions: the anomeric region (d5.6–4.9 for a-anomers and
d4.9–4.3 for h-anomers), the ring proton region (d4.5–
3.0), and the high field region with the methyl groups of
rhamnose (f d1.3) and acetyl substituents (d2.2–2.0).
FC42 sample exhibited one resonance for the –CH3 of
rhamnose and three peaks for the acetyl groups, indicating
multiple sites of substitution. Moreover, integration of theth values obtained for Cepacian
FC75 FC87 MVPC12 MDIIR129 MDIIP144
23 20 23 23 22
7 8 8 7 8
49 49 49 49 41
21 23 20 21 30
Fig. 3. 1H-NMR spectrum of the sample FC52 recorded at 50 jC. The
assignment of the anomeric signals attributed to the galactan polymer is
reported.
Fig. 2. 1H-NMR spectrum of the sample FC42 recorded at 50 jC. The
spectrum is divided in regions, as reported in the text.
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methyl signal for the rhamnose residue showed a content
of about 2.7 acetyl substituents per each rhamnose unit,
indicating the presence of more then two acetyl groups
per repeating unit. The anomeric region is generally a
good fingerprint for the comparison of samples of un-
known structure with characterised polymers. However,
substitution of a ring hydroxyl function with an acetyl
group causes the geminal proton signal to shift from the
ring proton region to the anomeric region, thus compli-
cating that part of the spectrum. Besides this difficulty,
the 1H-NMR spectrum of all samples was very similar to
that of Cepacian [8] (data not shown), apart from FC52
sample. In fact, its 1H-NMR spectrum (Fig. 3) showed
resonances that were not present in the other samples. In
the high field region of the spectrum, two low intensity
resonances at d2.55 and 1.87 were attributed to methylene
protons; the methyl protons of rhamnose gave two signals
at about d1.3, and integration of the peaks at d2.20
indicated 2.4 O-acetyl groups per rhamnose residue con-
tent. Besides the main signals present in all samples
examined, in the anomeric region, there were four other
resonances at d5.12, 4.93, 4.77, and 4.70. These signals,
together with the methylene proton peaks, are identical to
those found in the 1H-NMR spectrum of the exopolysac-
charide produced by the strain BTS13 [12] (Fig. 1,
Formula 2). Their assignment is reported in Fig. 3. The
signal at d4.93 belongs to the H-2 of the galactose
residue substituted with an acetyl group on C-2.
With the aim of better characterising the structure of the
polysaccharides, 1H-NMR spectra were recorded on de-
acetylated samples that exhibited the anomeric regions of
the spectra cleared of the signals due to the acetyl substitu-
tion. The anomeric regions of the 1H-NMR spectra were
compared with that of Cepacian [9] (Fig. 4a) and it was
evident that all the spectra contained the same resonances,
sometimes together with other peaks. In Fig. 4, only part ofthe anomeric regions is shown because of the overlapping of
the signals between 4.6 and 4.3 ppm with the residual HOD
resonance. The signals’ assignment is reported in Fig. 4a. On
the basis of the signals in the anomeric region and of their
integration data (Table 4), the samples were divided in three
groups. The sample FC52, characterised by signals belong-
ings to Cepacian and to the EPS produced by B. cepacia
strain BTS13, stands on its own (Fig. 4b). The samples
FC24, FC75, and MDIIR129 (Fig. 4c) had integration values
quite different from those of Cepacian, this feature being
particularly evident for rhamnose and mannose residues.
Moreover, they also had extraneous peaks in the region
d5.08–4.80. The samples FC30, FC42, FC87, MVPC12 and
MDIIP144 showed the same signals present in the 1H-NMR
spectrum of Cepacian together with small extraneous peak,
(Fig. 4d). Integration values of the anomeric resonances
were in good agreement with those of Cepacian.4. Discussion
In this study, the production and structure of EPSs
synthesised by both environmental and clinical strains of
B. cenocepacia were investigated for the first time. All
strains examined belonged to recA lineage IIIA or IIIB, the
two world-wide spread lineages, and, except for two IIIA
strains, they were genetically unrelated.
It is interesting that the environmental isolates produced
on average lower quantities of EPS than the clinical isolates.
Although this data needs to be corroborated using a larger
number of isolates, nevertheless, our preliminary findings
might indicate a characteristic of increased virulence in the
clinical strains.
In terms of the primary structure of the polymers pro-
duced, no major differences among the nine strains exam-
ined were observed, regarding both the origin, clinical or
environmental, and the recA lineage status. In fact, all
Fig. 4. Partial anomeric regions of the 1H-NMR spectra of the deacetylated samples. (a) Cepacian, (b) FC52, (c) FC24, FC75, and MDIIR129, (d) FC30, FC42,
FC87, MDIIP144, and MVPC12.
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(Fig. 1, Formula 1), the EPS most abundant among the
Bcc isolates examined up to now. Some of these strains
produced exclusively Cepacian, while others co-produced
also small amounts of other polymers, as indicated by the
NMR spectra and the linkage analysis data. Among thelatter, only the strain FC52, of clinical origin, produced
relevant amounts of another exopolysaccharide, whose
structure has already been reported in the literature [12]
(Fig. 1, Formula 2). Estimation of the relative quantities of
the two polysaccharides was achieved by integration of
NMR signals (data not shown). The values obtained showed
Table 4
Integration areas of the anomeric peaks
Sugar residue Exopolysaccharides samples
Cep FC24 FC30 FC42 FC75 FC87 MVPC12 MDIIR129 MDIIP144
a-GlcA 1.0 0.5 0.9 0.7 0.9 0.5 0.7 0.8 0.5
a-Rha 1.1 1.7 1.0 1.0 1.4 1.0 1.0 1.2 1.0
a-Gal 1.1 0.7 1.1 0.8 0.9 0.9 0.8 1.0 0.7
a-Man 0.9 1.0 1.0 1.0 1.4 1.0 1.0 1.7 1.0
h-Glc 1.0 0.4 1.1 0.7 1.0 0.7 0.9 1.0 0.7
h-Gala 1.5 1.3 1.7 1.4 1.6 1.2 1.5 1.7 1.3
a Integration of this signal was troublesome, due to overlapping peaks.
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19% w/w. Small discrepancies in the result paragraph
regarding the type and amount of sugars extraneous to
Cepacian are due to the different techniques used. Consid-
ering for example the sample MDPIIP144, the alditol
acetates analysis revealed a higher amount of glucose and
a lower amount of galactose, while the linkage analysis
indicated the presence of 6-linked galactose residue. This
may be explained considering that different reactions were
used in the two procedures and that components present in
less than 10% in the linkage analysis were not taken into
account. The NMR spectrum of MDPIIP144 showed three
extraneous peaks between 5.1 and 4.9 ppm. Since NMR
spectra are recorded on aqueous solutions of the samples
without any previous chemical treatment, they provide
reliable qualitative and quantitative data. However, 1H-
NMR chemical shifts cannot identify by themselves a
particular sugar and this is the reason one usually needs to
perform different types of experiments in order to determine
the structure of polysaccharides. The polysaccharide
depicted in Fig. 1, Formula 2, was already reported to be
produced not only by two other clinical strains of B. cepacia
[9,12], but also by Burkholderia pseudomallei [28,29], the
causative agent of melioidosis, an infectious disease of
humans and animals in Southeast Asia. Both Burkholderia
species colonise the lungs of the hosts, posing the question
of the biological role of the exopolysaccharide in the
infected organ. Furthermore, in a recent work, Mack and
Titball [30] showed that B. pseudomallei and B. cepacia
share identical insertion sequences. These findings in these
two closely related organisms point out that the transfer of
genetic material between them is highly probable, with the
possible emergence of pathogens with enhanced virulence
[31]. The latter hypothesis is supported by evidence for
bacteriophages capable of using both B. cepacia complex
and B. pseudomallei as bacterial hosts [32].
In conclusion, the current knowledge shows that Bcc
microrganisms produce four different exopolysaccharides
(Refs. [5,7–12,33] and this study) (Fig. 1), with the majority
of strains synthesising Cepacian. The latter polymer seems
to be characteristic of this bacterial complex and it has not
been described to be produced by other species.
The recent report by Chung et al. [5] underlines the
importance of EPS in lung infections. A spontaneous variantof the Bcc strain C1394 persisted in the lungs of an infected
mouse, while the parent strain was rapidly cleared. The
phenotype of the two strains was different, and among other
characteristics, the variant produced more EPS than the
parent one. It is interesting that they both produced the
same polysaccharide, Cepacian, and that the change
regarded the quantity and not the type of polymer produced.
The structure–function correlation of EPSs is relevant to
fully understand the biological activity of these molecules in
relation to bacterial life. EPSs may exhibit two general
functions: to constitute a physical barrier around bacterial
cells or bacterial colonies and to possess specific chemical
characteristics interfering with the host defence mechanisms.
As far as the physical barrier is concerned, it should consist of
a more or less loose matrix around bacterial cells. This may
be achieved with rigid polysaccharidic chains that give rise to
elongated macromolecules, which in turn are well suited to
set up a large number of self-intermolecular connections. A
study recently published by our group [11] pointed out the
rigidity of the Cepacian polymer backbone that was demon-
strated by means of viscosity and gyration radii measure-
ments. Such a characteristic is explained by the presence of
(1! 3) glycosidic bonds in the polysaccharide backbone and
by the high degree of substitution of the glucuronic acid
residue, which constitute a sterically hindered region.
Regarding the presence of specific chemical characteris-
tic, it is worth mentioning the frequent presence of acetyl
groups on bacterial exopolisaccharides. In fact, it was
reported that O-acetylation of specific hydroxyl functions
on sugar residues might confer bacterial resistance to host
phagocytes and complement [34], because the linkage to the
O-acetyl groups renders the hydroxyl functions no longer
available for binding the complement opsonins.
It has to be stressed that a limited amount of Bcc strains
was considered till now and an investigation of EPSs
produced by the nine different Bcc genomovars might still
reserve some surprises.Acknowledgements
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